Transwell assays revealed that treatment with GW4869 decreased the promotion of M2 CM on the migration abilities of Huh7, PLC and MHCC-97H HCC cells (Supplementary Figure 5A). The gene discussed is HSPG2; the disease is hepatocellular carcinoma.